Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Vitamin D may help prevent or reduce hair loss after COVID-19.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Exosomes show promise for improving wound healing, reducing aging signs, preventing hair loss, and lightening skin but require more research and better production methods.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Extracellular vesicles show promise as treatments but need more research for safety and effectiveness.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.

Secondary syphilis in Cali, Colombia, shows high Treponema pallidum presence and challenges in early diagnosis, needing better public health strategies.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

SVF may improve nanofat treatment for acne scars, but more research is needed.

Enhancing antioxidant responses can improve treatments for various diseases.

Improving CRISPR/Cas systems can make gene editing more efficient and precise.

Exosomes from different stem cell sources affect immune cells and brain cell growth differently.

The pandemic worsened physical and mental challenges for women with PCOS.

Adipose-derived stem cells show promise in treatments but need more research for safety, especially in cancer.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

Biliary fibrosis is crucial in liver diseases and understanding it can help prevent and treat these conditions.

Females are more likely than males to experience long-COVID symptoms and heart issues.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Polycystic ovary syndrome, a disorder causing menstrual issues and infertility, can be treated with lifestyle changes, medication, herbal remedies, surgery, and assisted reproductive techniques like artificial insemination and IVF.

COVID-19 may worsen Parkinson's disease by affecting certain brain proteins.

Multitarget drugs are needed to better treat complex diseases.

Turning off a specific gene in stem cells speeds up skin healing by helping cells move better.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.